Combatting a Silent Epidemic: Best Practices for Overcoming the Challenges of NAFLD Clinical Trials
As our understanding of Non-Alcoholic Fatty Liver Disease (NAFLD) and diagnostic approaches has evolved, so too have the best practices to be considered when implementing a NAFLD clinical drug trial. This article discusses the current challenges confronting NAFLD clinical trials, as well as ‘best practices’ to be aware of when designing such trials.
Copyright: International Clinical Trials, Winter 2023, pages 12-15. © Samedan Ltd